Two new appointments
🎉 Exciting Updates from ENOTTA! 🎉 We are thrilled to announce two new appointments to our COST Action ENOTTA team: 1️⃣ Prof. Güldal İnal Gültekin joins us as the Co-Leader…
News & Events
New Webinar Series on Pharmacoeconomics in Therapeutic Drug Monitoring of Antibodies in Chronic Inflammatory Diseases
We are excited to announce the start of a new webinar series organized by Working Group 4 (WG-4) of ENOTTA. This series, titled “Pharmacoeconomics in Therapeutic Drug Monitoring of Antibodies…
ENOTTA Model-Informed Precision Dosing Training School
COST Action ENOTTA, the European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases (CA21147), is pleased to announce a unique opportunity for researchers and healthcare practitioners to…
Leadership Transition in ENOTTA Working Group 3
We are excited to announce a leadership change in ENOTTA Working Group 3, “Assay Standardisation and Structured Overview on Participating Hospitals/Research Centres.” We extend our heartfelt gratitude to Prof. Silje…
COST Action ENOTTA (CA21147) was presented at the Antibody Industrial Symposium (AIS)
As part of our dissemination activities, the , held on 20-21 June 2024 in Montpellier, France. The workshop, titled “ENOTTA – European Network on Optimising Treatment with Therapeutic Antibodies in…
New EQA survey
WG3 just opened a short survey focusing on External Quality A (EQA) schemes for therapeutic drug monitoring used to guide clinical decision making. If you would like to participate, the…
Extended Core Group Meeting in Lemnos, Greece 29th-31th May 2024.
The Extended Core Group meeting of COST Action CA 21147 ENOTTA was held in the picturesque island of Lemnos, Greece, from May 29th to 31st, 2024! ENOTTA, the “European Network…
Exciting news! Our research on therapeutic drug monitoring of monoclonal antibodies takes a major step forward!
We’re thrilled to announce the publication of our first paper titled: “Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe” This…
ENOTTA Webinars on Model-informed therapeutic drug monitoring of antibodies in chronic inflammatory diseases
We are excited to announce our upcoming webinar series “Model-informed therapeutic drug monitoring of antibodies in chronic inflammatory diseases: Assembling a multidisciplinary puzzle“. The webinars will take place every second…
COST Action ENOTTA WG2-WG3 Joint Publication is available online now!
Based on results from the COST Action ENOTTA recent survey, ENOTTA members have penned an overview of laboratories active in the field of TDM of therapeutic antibodies and their approaches…